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E-mail address: parecheg@med.ucm.es (P.A. RecheFunctional characterization of proteins belonging to the MHC I superfamily involves knowing their
cognate ligands, which can be peptides, lipids or none. However, the experimental identiﬁcation of
these ligands is not an easy task and generally requires some a priori knowledge of their chemical
nature (ligand-type speciﬁcity). Here, we trained k-nearest neighbor and support vector machine
classiﬁers that predict the ligand-type speciﬁcity MHC I proteins with great accuracy. Moreover,
we applied these classiﬁers to human and mouse MHC I proteins of uncharacterized ligands, obtain-
ing some results that can be instrumental to unravel the function of these proteins.
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V.1. Introduction
The major histocompatibility complex class I (MHC I) protein
superfamily encompasses a large number of glycoproteins includ-
ing classical MHC I molecules and non-classical and MHC I-like
molecules [1]. Because of their crucial role in graft rejection and
antigen presentation, classical MHC I molecules (hereafter MHC
Ia) were the ﬁrst to be discovered and studied. In humans, classical
MHC molecules are for historical reasons, known as human leuko-
cyte antigens (HLAs).
MHC Ia molecules are cell surface expressed glycoproteins con-
sisting of an a chain (encoded inside the MHC gene region) paired
with b2-microglobulin (b2m), and their function is to present pep-
tides for immune recognition by CD8 T cells [2]. MHC I-bound pep-
tides are nested in the a1a2 domain of the MHC I molecule (MHC I
a1a2 domain). The structural presence of this a1a2 domain is the
signature that relates all the members of the MHC I superfamily.
Non-classical and MHC I-like molecules (hereafter MHC Ib mol-
ecules) were discovered later and differ in many aspects fromMHCal Societies. Published by Elsevier
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).Ia molecules. First of all, MHC Ib molecules do not conform a single
protein family but comprise several highly divergent protein fam-
ilies that are structurally related to MHC Ia molecules. MHC Ib mol-
ecules can be encoded inside or outside the MHC loci, display a
wide range of functions and, in contrast to MHC Ia molecules, are
either non-polymorphic or exhibit little polymorphism [3,4].
Moreover, while MHC Ia molecules can only bind peptides, there
are known examples of MHC Ib molecules that bind peptides
(e.g., HLA-E and HLA-G, and their mouse functional counterparts
Qa1 (H2-T23) and Qa2 (H2-Q9), respectively), others that bind lip-
ids (e.g., CD1 antigens; ZAG, zinc-binding alpha-2-glycoprotein 1;
EPCR, Endothelial Protein C Receptor) and some that do not have
any ligand; they have an empty groove (e.g., MICA&B, mouse TL
antigens, ULBP1,2,&3, HFE and FcRn) [4].
Functional characterization of MHC I proteins can be challeng-
ing and generally requires knowing their cognate ligands. How-
ever, the identiﬁcation of ligands of MHC I proteins, if any, is a
difﬁcult task, which generally requires having some a priori knowl-
edge of the chemical nature of the ligand (ligand-type speciﬁcity)
to guide the experimental efforts. Therefore, in this study, we built
machine learning-based classiﬁers to predict the ligand-type spec-
iﬁcity of these proteins. Subsequently, we applied such models to a
number of human and mouse MHC Ib molecules of uncharacter-
ized ligands obtaining some interesting results, such as the binding
of lipids of the H2-M1 family and the lack of ligand of MR1, that
could be instrumental to unravel the function of these proteins.B.V. Open access under CC BY-NC-ND license.
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2.1. MHC I dataset
We used a dataset (MHCI556 dataset) consisting of 556 non-
overlapping and unique sequences of MHC I proteins of known li-
gand-type speciﬁcity of which 355 bind peptides (P), 84 bind lipids
(L) and 117 do not bind anything (N). Sequences in the MHCI556
dataset were collected and processed as previously described [5].
The sequences only comprise the a1a2 domain and all range be-
tween 170 and 189 amino acids and were subjected to a se-
quence-similarity reduction schema, setting the maximum
sequence similarity allowed between two sequences to an e-score
of 925 using a BLOSUM62 matrix [5]. Sequence identity within the
P, L and N groups is 63.69 ± 17.62, 41.8 ± 15.37 and 36.37 ± 21.07,
respectively.
2.2. Building and evaluation of machine learning-based models
We used the Waikato Environment for Knowledge Analysis
(WEKA) [6] to built and evaluate machine learning (ML)-based
classiﬁcation models. As input for features for training, we used
the amino acid composition of the sequences (attributes) and their
known ligand-type speciﬁcity (P: Peptides, L: Lipids and N: No li-
gand) (classiﬁcation instances). WEKA provides a large collection
of ML algorithms for classiﬁcation, and in this study, we selected
k-Nearest Neighbor algorithm (kNN) and support vector machines
(SVMs) [7,8]. Brieﬂy, kNN classiﬁes objects based on the majority
class of their k nearest neighbors in the training sets. The vicinity
between objects is computed as a Euclidean distance. SVMs were
ﬁrst introduced to classify linear data and are based on decision
planes that deﬁne decision boundaries. A decision plane is one that
separates between a set of objects having different class member-
ships. For non-linear data, SVMs ﬁrst use a function (kernel) to map
the input data onto a higher m-dimensional space, where a linear
model based on decision planes can then achieve an optimal sepa-
ration of the data. Here we used a Gaussian Radial Basis Function
(RBF-kernel) and a Polynomial function (P-kernel), as kernels for
SVMs.
Model reﬁnement was achieved in 10-fold cross-validation
experiments varying the relevant parameters of the ML algo-
rithms. In a 10-fold cross-validation, the data are randomly par-
titioned into 10 sets, and each set is tested using classiﬁers
trained on the sum of the remaining sets. Thus, kNN were re-
ﬁned with regard to k, the number of neighbours, while SVMs
were reﬁned with regard to C, the complexity parameter – al-
lows one to trade off training error versus model complexity –
in combination with c for the RBF-kernel (deﬁnes de width of
the Gaussian function) and E for the P-kernel (exponent of the
polynomial function).
As measures of performance to evaluate the models, we used
sensitivity (SE), speciﬁcity (SP) and accuracy (ACC) in percentages,
which for a 3-class classiﬁcation can be computed using Eqs. (1)–
(3), respectively,
ACC ¼ 100 PP þ LL þ NN
P þ Lþ N
 
ð1Þ
SE ¼ 100=3 PP
P
þ LL
L
þ NN
N
 
ð2Þ
SP ¼ 100=3 N þ L ðNP þ LPÞ
N þ L
 
þ N þ P  ðNL þ PLÞ
N þ P
 
þ P þ L ðPN þ LNÞ
P þ L
 
ð3ÞP, L, N, are the total number of instances (in our case, MHC I pro-
teins) belonging to the corresponding class and Pi, Li, Ni with
i = (P, L, N), represents predicted instances and their class. For
example, PP numbers P instances predicted as P, while PN and PL,
number P instances classiﬁed as N and L, respectively. Note that
SE and SP are computed for each of the tree classes (P, L, N) while
ACC corresponds to the percentage of properly predicted instances.
Because we run each 10-fold cross-validation 10 times, for each
model we obtained 100 different estimates of the noted parameters
of performance, computing the mean and standard deviations. To
compare the performance of the models, we carried our paired t-
test in WEKA over the ACC [6].2.3. Other procedures
We used MULTIPROT [9] for superimposing protein 3D-struc-
tures of MHC I proteins and STACCATO [10] for deriving a multiple
sequence alignment (MSA) from the superimposed structures.
MHC Ia and Ib proteins were aligned with TCOFFEE [11], using a
seed structural alignment. We obtained dendrograms from the rel-
evant MSAs using the Neighbor-joining method [12], and we ad-
dressed their reliability using bootstrapping [13] with 1000
replications. We also used bootstrapping with 1000 replications
to evaluate the performance of ML-based models on holdout pro-
tein sequences with an increasing number of random mutations
at random variable sites (PERL script to mutate sequences will be
provided upon request). BLAST searches were executed with de-
fault settings against a BLAST-formatted database derived from
the MHCI556 dataset in FASTA format in which each distinct MHC
I sequence had a header with a label indicating the nature of its li-
gand (P: peptides, L: lipids and N: No ligand).3. Results and discussion
3.1. MHC I sequence similarity space
In order to investigate whether one could deﬁne the ligand-type
speciﬁcity of MHC I proteins (P, L, N) by sequence similarity ap-
proaches, we superimposed the 3D-structures of the a1a2 domain
of representative MHC I proteins (Fig. 1A), obtained a structured-
based alignment (Fig. 1B) and subsequently derived a sequence
similarity-based dendrogram (Fig. 1C). We found that the selected
MHC I proteins fail to cluster in just three distinguishable groups
matching their ligand-type speciﬁcity (Fig. 1C). Thus, while some
MHC I proteins group according to their ligand-type speciﬁcity
(e.g., the lipid-binding CD1 antigens and EPCRs, and the peptide-
binding classical and non-classical MHC I proteins), other mole-
cules like ZAG, that bind lipids, and TLA, HFE, and FcRN, that have
no ligand, appear unrelated to the molecules of the relevant
groups. Also, TLA, which does not bind any ligand, is much closer
to the group of peptide-binding MHC I proteins than to those that
do not bind anything. Likewise, using TreeDet [14], a popular and
robust program to explore sequence space, we were unable to
identify key signature residues allowing the distinction of MHC I
proteins according to the nature or their ligand. These results are
likely due to the fact that the division between MHC I proteins
by ligand-type speciﬁcity is functionally relevant but it is not phy-
logenetic. For example, TLA and MICA, both incapable of binding
any ligand, are, beyond having the MHC I fold, completely unre-
lated and shared sequence identity of just 24.06%. The sequence
identity between all the proteins considered in the structure-based
alignment is shown in Supplementary ﬁle 1.
Since the ligand-type speciﬁcity of MHC I proteins could not be
properly distinguished in the MHC I sequence similarity space, in
this work, we approached the task of predicting the type of ligand
Fig. 1. MHC I sequence similarity space. (A) Structural superimposition of MHC I proteins. The ﬁgure depicts a 3D-structure superimposition of MHC I proteins (a1a2 domain)
that are known to bind peptides (in blue; PDBs: 1HHG, 1XH3, 1IM9, 2VAA, 1YDP, 1MHE, 1K8D and 1MHC), lipids (in yellow; PDBs: 1XZ0, 2H26, 2GAZ, 1LQV and 1ZAG), and
have no bound ligands (in grey; PDBs: 1A6Z, 1B3J, 1JE6, 3FRU, 1KCG and 1NEZ). (B) Protein MSA obtained from the structural superimposition shown in panel A. Amino acid
sequence numbering and secondary structures elements match those of the human MHC I molecule HLA-A⁄0201 (PDB: 1HHG). For clarity, some amino acids in loop regions
have been deleted (numbers shown in square brackets). Identical and conserved residues are shadowed in black and grey, respectively. (C) Neighbor-joining tree built from
the structure-based alignment shown in panel B. The groups of sequences that appear shadowed cluster with a bootstrap reliabilityP 90%. Proteins that do not group with
other proteins having the same ligand-type speciﬁcity are highlighted in red. The data to reconstruct this dendrogram is provided in Supplementary ﬁle 2.
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3.2. Evaluation of ML-based classiﬁers in cross-validation
We built our ML-based models by training several ML algo-
rithms on the amino acid composition of 556 non-overlapping
and unique MHC I protein sequences (a1a2 domain) of know li-
gand-type speciﬁcity (MHCI556 dataset): 355 bind peptides (P),
84 bind lipids (L) and 117 do not bind anything (N) (Table 1).
Speciﬁcally, we trained k-Nearest Neighbor algorithm (kNN) and
support vector machines (SVMs) with polynomial (SVM-Pk) and
RBF-kernels (SVM-RBFk). We selected these algorithms becauseof their reliability, simplicity and speed [7]. We used 10-fold
cross-validations to built, evaluate and optimize the models
(Fig. 2).
The best performance was obtained using SVM-RBFk, which
reached an ACC of 100.0 ± 0.0%; not a single MHC I protein was
misclassiﬁed (Fig. 2B). Next to these results were those obtained
using kNN (ACC = 99.93 ± 0.35%, SE = 99.98 ± 0.03%, SP = 99.82 ±
1.16%), which misclassiﬁed one protein (Fig. 2B). The performance
achieved using SVM-Pk (ACC = 99.46 ± 0.87, SE = 99.96 ± 0.05,
SP = 99.51 ± 1.82) was slightly lower than that obtained with
kNN; three proteins were misclassiﬁed (Fig. 2B). It could be well
argued that these results are conditioned by the fact that the
MHCI556 dataset is imbalanced; the peptide-binding group is much
Table 1
MHC I proteins in the MHCI556 dataset.
MHCI Species Seqs. Ligand
HLA-[ABC] Human 111 P
DLA-88 Dog 22 P
SLA-[123] Swine 51 P
BoLA-N Cattle 39 P
OLA-N Sheep 12 P
ONMY-UBA Rainbow trout 29 P
SASA-UBA Atlantic Salmon 27 P
RT1-A Rat 21 P
H2-X Mouse 26 P
HLA-E Human and Primates 6 P
HLA-G Human and primates 1 P
H2-T23(Qa1) Mouse and Rat 4 P
H2-Q9 Mouse 2 P
H2-M3 Mouse and Rat 4 P
CD1[A-E] Vertebrates 71 L
ZAG Vertebrates 6 L
EPCR Vertebrates 7 L
MICA&B Vertebrates 38 N
HFE Vertebrates 6 N
MILL1&2 Mouse and Rat 4 N
FcRN Mammals 9 N
ULBP Vertebrates 45 N
H2-T3(TLA) Mouse and Rat 15 N
We only included the sequence of the a1a2 domain. The corresponding author will
provide this dataset upon writing request.
Fig. 2. Predictive performance of ML-based classiﬁers. (A) Graph depicting the ACC
(dark grey bars), SE (light grey bars) and SP (white bars) in percentage achieved by
ML-based classiﬁers (abscissas) predicting the class (P, L, N) of the molecules
included in the MHCI556 dataset in cross-validation. ML-based classiﬁers consisted
k-Nearest Neighbor (kNN) and SVM with polynomial (SVM-Pk) and RBF (SVM-
RBFk) kernels. We represent average values of ACC, SE, and SP with their
corresponding standard deviations as negative errors bars. Note that we plot
standard deviations not standard errors. Also, the y-scale starts at 96%. (B)
Confusion matrix obtained in a representative 10-fold cross-validation experiment.
The performance of ML-based classiﬁers shown in the ﬁgure was achieved using the
following parameters: kNN: K = 4; SVM-Pk: E = 3, C = 1; SVM-RBFk: c = 6, C = 1.
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properly classiﬁed regardless of their class (Fig. 2B). Moreover,
we virtually obtained the same results (Supplementary Fig. S1)
using a dataset (MHCI334 dataset) encompassing only 133 MHC I
peptide-binding proteins (P). The MHCI334 dataset is described in
Supplementary Table S1.
In sum, classifying the highly divergent MHC I protein families
into the three deﬁned groups was a surprisingly simple task for ML,
which on the one hand highlights the quality of the assembled
dataset and on the other suggests that the ligand-type speciﬁcity
of MHC I proteins is readily imprinted in their amino acid compo-
sition. In comparison, accurate classiﬁcation of biological se-
quences using ML often requires many more input features suchTable 2
Evaluation of ML-based classiﬁers on holdout MHC I proteins.
Holdout group Perform
Lig.a Seq.b Algorith
HLA-[ABC] P 111 kNN
SVM-Pk
SVM-RB
OLA-& BoLA-N (sheep & cattle) P 51 kNN
SVM-Pk
SVM-RB
SLA-[123] (Swine) P 51 kNN
SVM-Pk
SVM-RB
RT1-A & H2-X (murine) P 47 kNN
SVM-Pk
SVM-RB
SASA- & ONMY-UBA (ﬁsh) P 56 kNN
SVM-Pk
SVM-RB
CD1[A-E] L 71 kNN
SVM-Pk
SVM-RB
EPCR L 7 kNN
SVM-Pkas using dipeptide composition [15] However, it is true that those
studies involved binary classiﬁcations of a group of related pro-
teins (e.g., Histones) from the remaining universe of proteins
(e.g., non-Histones). Instead, here we performed a multiclass
classiﬁcation.
3.3. Evaluation of ML-based classiﬁers on holdout MHC I proteins
We carried out several validations on distinct independent
datasets consisting on entire groups of MHC I proteins (holdout
sequences) that were drawn from the MHCI556 dataset prior to
model building. Our goal was to explore whether ML-based clas-
siﬁers built and optimized in cross-validation can predict the li-
gand-type speciﬁcity of MHCI proteins differing entirely from
those used for model building as well as to identify MHC I pro-
teins that are critical to guarantee the robustness of the method.
The results of these analyses are depicted on Table 2 and sum-
marized next.ance in cross-validationc Classiﬁcationd
m ACC P L N
99.97 ± 0.22 111 0 0
99.33 ± 1.17 111 0 0
Fk 100.0 ± 0.00 111 0 0
99.96 ± 0.25 51 0 0
99.46 ± 0.78 51 0 0
Fk 100.0 ± 0.00 51 0 0
99.98 ± 0.18 51 0 0
99.40 ± 1.12 51 0 0
Fk 100.0 ± 0.00 51 0 0
99.90 ± 0.42 47 0 0
99.53 ± 1.02 47 0 0
Fk 100.0 ± 0.00 47 0 0
100.0 ± 0.0 27 22 7
99.43 ± 1.00 18 10 28
Fk 100.0 ± 0.00 25 10 21
99.92 ± 0.31 6 10 55
99.80 ± 0.66 6 28 37
Fk 100.0 ± 0.0 4 7 60
99.98 ± 0.18 0 7 0
99.41 ± 1.02 0 7 0
(continued on next page)
Table 2 (continued)
Holdout group Performance in cross-validationc Classiﬁcationd
Lig.a Seq.b Algorithm ACC P L N
SVM-RBFk 100.0 ± 0.00 0 7 0
ZAG L 6 kNN 99.94 ± 0.31 4 0 2
SVM-Pk 99.75 ± 0.63 5 0 1
SVM-RBFk 100.0 ± 0.00 2 0 4
MICA&B N 38 kNN 99.96 ± 0.25 0 0 38
SVM-Pk 99.54 ± 0.99 0 0 38
SVM-RBFk 99.96 ± 0.27 0 0 38
HFE N 6 kNN 99.96 ± 0.25 1 0 5
SVM-Pk 99.44 ± 0.98 3 0 3
SVM-RBFk 100.00 ± 0.00 0 0 6
ULBP N 45 kNN 99.80 ± 0.59 3 21 21
SVM-Pk 99.61 ± 0.97 9 11 25
SVM-RBFk 99.88 ± 0.46 1 7 37
FcRN N 9 kNN 99.96 ± 0.25 6 0 3
SVM-Pk 99.44 ± 0.92 0 3 6
SVM-RBFk 100.0 ± 0.00 0 3 6
TLA N 15 kNN 99.94 ± 0.31 15 0 0
SVM-Pk 99.94 ± 0.41 15 0 0
SVM-RBFk 100.0 ± 0.00 15 0 0
a Known ligand-type class of holdout sequences (P: bind peptides; L: bind lipids; N: no ligand).
b Number of holdout sequences.
c Models were built and optimized on MHC I datasets without the holdout proteins in 10-fold cross-validation experiments that were repeated 10 times. ACC depicted in
table correspond to that of the optimal model.
d Class assignment (predicted ligand-type speciﬁcity: P, L, N) of holdout sequences using models built and optimized on datasets lacking that same sequences. Shadowed
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reached in cross-validation an extraordinary accuracy (ACCP
99.3%) that mirrored the results obtained on the full MHCI556 data-
set (ACC SVM-RBFk > ACC kNN > ACC SVM-Pk). In many occasions,
ML-based classiﬁers were able to predict the right ligand-type
speciﬁcity of the proteins that were removed prior to model build-
ing (Table 2). Moreover, we noted that classiﬁers that performed
best in cross-validation classiﬁed the holdout proteins with fewer
errors (see results involving HFE, ULBP, and FcRn holdout tests in
Table 2). However, we also found MHC I proteins, such as CD1 anti-
gens ZAG and TLA proteins (Table 2), that could not be classiﬁed
appropriately, indicating that it is critical to include them in the
training datasets. ML-based models were also unable to predict
peptide binding for all MHC I proteins form ﬁsh (Table 2). Although
there is not enough experimental evidence, it is reasonable, yet
arguable, to think that all these ﬁsh MHC I should bind peptides;
they have been classiﬁed as classical MHC I molecules in special-
ized databases (see http://www.ebi.ac.uk/ipd/mhc/ﬁsh/index.
html).
We also investigated the potential tolerance of ML-models to
mutations in the testing data. Speciﬁcally, we evaluated the ability
of the three SVM-RBFk models trained on datasets lacking HLA I,
EPCR and MICA&B proteins to predict the correct class of the rele-
vant proteins modiﬁed with an increasing number of random
mutations at random variable sites. The results indicate that at
least these models are quite tolerant to mutations in the tested
proteins (decreasing the percentage of properly predicted in-
stances to 80% required more than 30 mutations) (see Supplemen-
tary Fig. S2).
3.4. Predicted ligand-type speciﬁcity of MHC Ib molecules of
uncharacterized ligands
There are a number of mouse and human MHC Ib molecules
whose ligands, if any, have not been characterized yet. In humans,
the MHC Ib molecules of unveriﬁed ligands are HLA-F and MR1,
whereas in mouse are MR1 and a number molecules encoded bythe H2-T, H2-Q and H2-M loci. Here, we predicted the ligand-type
speciﬁcity of these proteins (a1a2 domain) using the ML-based
classiﬁers trained on the MHCI556 dataset and compared the results
with those resulting from a BLAST search using the corresponding
a1a2 domain sequences against the MHCI556 dataset (ligand-type
speciﬁcity was assigned to that of the closest hit). To verify the
generalization power of our classiﬁers, we also predicted the li-
gand-type speciﬁcity of two MHC I molecules from chicken
(BF2⁄2101 and YF1⁄7.1) as well as UL18, H2-T9, H2-T10 and H2-
T22. All these proteins, despite their known binding ability, were
not used for model building (they were not included in the
MHCI556 dataset). UL18 is a viral MHC I-like molecule from human
cytomegalovirus that is known to bind peptides [16], whereas H2-
T9, H2-T10 and H2-T22 are closely related murine MHC Ib mole-
cules, which are incapable of binding any ligand because of having
a truncated a1a2 domain [17,18]. As for the chicken MHC I pro-
teins, BF2⁄2101 binds peptides [19] while YF1⁄7.1 appears to bind
some unknown non-classical ligand (perhaps a lipid) [20]. A
phylogenetic tree depicting the analyzed proteins is shown Fig. 3.
The predictions are summarized in Table 3 and we will next high-
light some of the results.
UL18 and both chicken MHC I proteins were predicted to bind
peptides using BLAST and the ML-based classiﬁers (Table 3). How-
ever, only ML-based classiﬁers predicted the lack of ligand of
H2-T9, H2-T10 and H2-T22 (Table 3). In fact, BLAST predicted
peptide-binding for all the MHC Ib proteins that were tested
(Table 3). These results suggest that the ML approach is more suit-
able to predict the ligand-type speciﬁcity of MHC I proteins than
the BLAST approach. Nevertheless, the two approaches are not
necessarily exclusive but complementary.
ML-based classiﬁers revealed MHC Ib proteins with ligand-type
speciﬁcities that could not have been anticipated using sequence
similarity analyses. Thus, ML-based classiﬁers predicted that the
mouse H2-M1 and H2-M10 proteins (Fig. 3), which are expressed
in vomeronasal sensory neurons (VNS) [21], bind lipids and have
no ligand, respectively (Table 3). The lack of ligand of H2-M10 pro-
teins is consistent with the available crystal structure of H2-M10.5
Fig. 3. Sequence relationship between human and mouse MHC I proteins. Figure depicts a Neighbor-joining dendrogram from an MSA of the a1a2 domain of various
proteins, including mouse and human MHC Ia and Ib molecules of uncharacterized ligands (Genbank accession numbers shown in parenthesis). The MHC Ib proteins that
were the subject of the predictions are shown in red. MHC I clusters with more than three members and a bootstrap conﬁdence >90% are shadowed as follows: blue if they
bind peptides, yellow if they bind lipids and grey in they have no ligand. The molecules labeled as HLA Ia consist of human classical MHC I proteins. The molecules labeled as
mMHC Ia & H2-Q are mouse classical MHC I molecules and non-classical MHC I molecules encoded by the mouse H2-Q loci, respectively. In Supplementary ﬁle 3, we provide
the data to reconstruct this dendrogram.
Table 3
Predicted ligand-type speciﬁcity of selected MHC Ib proteins.
Molecule Gene ID GB ACNb Predicted ligand-type speciﬁcity
BLAST SVM-Pk kNN SVM-RBFk
UL18 3077466 YP_081477 P P P P
BF2(BF2⁄2101) 425389 NP_001026509 P P P P
YF1⁄7.1 427746c NP_001074336 P P P P
HLA-F 3134 NP_001091948 P P P P
H2-Q1 15006 NP_034520 P P P P
H2-Q2 15013 NP_034522 P P P P
H2-M2 14990 NP_032230 P P P P
H2-M1 224756 NP_808304 P N P L
H2-M9 14997 NP_032231 P L L L
H2-M11 224754 NP_808303 P L L L
H2-M10.1 14985 NP_038572 P N N N
H2-M10.2 333715 NP_808591 P N N N
H2-M10.3 110696 NP_963902 P N N N
H2-M10.4 224753 NP_808302 P N P N
H2-M10.5 224761 NP_808305 P P P N
H2-M10.6 399549 NP_963905 P N P N
H2-T24 15042 NP_032233 P N N N
H2-T9a 15051 NP_034529 P N N N
H2-T10a 15024 NP_034525 P N P N
H2-T22a 15039 NP_034527 P N N N
mMR1 15064 NP_032235 P N N N
hMR1 3140 NP_001522 P N N N
Predictions were carried out using only the a1a2 domains of the relevant proteins.
a Sequence length shorter than training sequences.
b Genbank accession numbers.
c Gene annotated in NCBI as MR1 major histocompatibility complex, class I-related, most likely by mistake.
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with H2-M1 proteins in VNS [21], and we speculate that likely
these receptors recognize lipidic pheromones presented by H2-
M1 proteins.
ML-based classiﬁers also predicted that MR1 does not bind any
ligand. MR1 (MHCI-related, class I, molecule) is a highly conserved
MHC Ib molecule, which has been shown to restrict a sub-popula-
tion of ab T cells named MAIT (Mucosal-associated invariant T
cells) [23]. The expression of MR1 appears to be TAP and protea-
some independent but yet some authors have found evidence sup-
porting antigen-presentation function for MR1, possible of
peptides [24–26]. Moreover, a group has indicated that MR1 pre-
sents a-mannosyl glycolipids to invariant V a19-J a33 MAIT cells
[27], although others have failed to conﬁrm these ﬁndings [28].
While it is possible that MR1 binds molecules that are different
from peptides or lipids, our results indicate that MR1 function
and restriction of MAIT cells might be independent of antigen
presentation.
Because it is not clear whether all of the classical MHC I proteins
from ﬁsh included in the MHCI556 dataset (Table 1) do really bind
peptides, we repeated all these predictions using ML-based models
trained without the ﬁsh proteins (MHCI500 dataset). The results
were largely the same, as shown in Supplementary Table S2.
4. Conclusions and limitations
Currently, there is a plethora of methods to predict peptide
binding to speciﬁc MHC Ia molecules [29], but surprisingly, until
now no method was available to predict whether any uncharacter-
ized member of the MHC I protein family can bind any ligand at all,
and if so, the nature of such ligand (peptides or lipids). This infor-
mation is key to lead the experiments that allow the identiﬁcation
of the relevant ligands. Upon an original multi-class classiﬁcation
approach, we developed here ML-based classiﬁers that achieve
such task with great accuracy and generalization power. Prediction
of the ligand-type speciﬁcity of MHC I proteins using our classiﬁers
is available for free public use at http://imed.med.ucm.es/MHCLIG/.
It is important to stress that the classiﬁers developed here can only
predict the three known ligand-type speciﬁcities of MHC I proteins
(P, L and N). If there would be MHC I proteins with other, yet to be
characterized, type of ligands (e.g., sugars, nucleotides, etc.) the
breath of our predictions will be clearly limited.
Acknowledgements
We wish to thank Dr. Alfonso Valencia for helpful comments.
This work was supported by the Ministerio de Ciencia e Innovación
of Spain (grants SAF2006-07879 and SAF2009-08103 to P.A.R. and
grant SAF2007-60578 to E.M.L.), the Spanish Ministry of Health
(grant PI080125 to E.M.N.), the Comunidad Autonoma de Madrid
(grant CCG08-UCM/BIO-3769 to P.A.R.) and the Universidad Com-
plutense de Madrid (grant Gr58/08 920631 to E.M.N., E.M.L. and
P.A.R.).
Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at doi:10.1016/j.febslet.2011.10.007.References
[1] Maenaka, K. and Jones, E.Y. (1999) MHC superfamily structure and the
immune system. Curr. Opin. Struct. Biol. 9, 745–753.
[2] Townsend, A. and Bodmer, H. (1989) Antigen recognition by class I-restricted T
lymphocytes. Annu. Rev. Immunol. 7, 601–624.
[3] Braud, V.M., Allan, D.S. and McMichael, A.J. (1999) Functions of nonclassical
MHC and non-MHC-encoded class I molecules. Curr. Opin. Immunol. 11, 100–
108.
[4] Rodgers, J.R. and Cook, R.G. (2005) MHC class Ib molecules bridge innate and
acquired immunity. Nat. Rev. Immunol. 5, 459–471.
[5] Martínez-Naves, E., Lafuente, E.M. and Reche, P.A. (2011) Classiﬁcation of MHC
I proteins according to their ligand-type speciﬁcity in: 10th International
Conference on Artiﬁcial Immune Systems (Liò, P., Nicosia, G. and Stibor, T.,
Eds.), pp. 55–65, Springer-Verlag Cambridge, England, UK.
[6] Frank, E., Hall, M., Trigg, L., Holmes, G. and Witten, I.H. (2004) Data mining in
bioinformatics using WEKA. Bioinformatics 20, 2479–2481.
[7] Wu, X. et al. (2008) Top 10 algorithms in data mining. Knowl. Inf. Syst 14, 1–
37.
[8] Dasarathy, B.V. (1991) Nearest neighbor (NN) norms: NN pattern classiﬁcation
techniques, IEEE Computer Society Press, Los Alamitos, California.
[9] Shatsky, M., Nussinov, R. and Wolfson, H.J. (2004) A method for simultaneous
alignment of multiple protein structures. Proteins 56, 143–156.
[10] Shatsky, M., Nussinov, R. and Wolfson, H.J. (2006) Optimization of multiple-
sequence alignment based on multiple-structure alignment. Proteins. 62, 209–
217.
[11] Notredame, C., Higgins, D.G. and Heringa, J. (2000) T-Coffee: A novel method
for fast and accurate multiple sequence alignment. J. Mol. Biol. 302, 205–217.
[12] Firestine, S.M., Nixon, A.E. and Benkovic, S.J. (1996) Threading your way to
protein function. Chem. Biol. 3, 779–783.
[13] Felsenstein, J. (1985) Conﬁdence limits on phylogenies: An approach using the
bootstrap. Evolution 39, 783–791.
[14] Carro, A., Tress, M., de Juan, D., Pazos, F., Lopez-Romero, P., del Sol, A., Valencia,
A. and Rojas, A.M. (2006) TreeDet: a web server to explore sequence space.
Nucleic Acids Res. 34, W110–W115.
[15] Bhasin, M., Reinherz, E.L. and Reche, P.A. (2006) Recognition and classiﬁcation
of histones using support vector machine. J. Comput. Biol. 13, 102–112.
[16] Yang, Z. and Bjorkman, P.J. (2008) Structure of UL18, a peptide-binding viral
MHCmimic, bound to a host inhibitory receptor. Proc. Natl. Acad. Sci. USA 105,
10095–10100.
[17] Crowley, M.P., Fahrer, A.M., Baumgarth, N., Hampl, J., Gutgemann, I., Teyton, L.
and Chien, Y. (2000) A population of murine cd T cells that recognize an
inducible MHC class Ib molecule. Science 287, 314–316.
[18] Shin, S., El-Diwany, R., Schaffert, S., Adams, E.J., Garcia, K.C., Pereira, P. and
Chien, Y.H. (2005) Antigen recognition determinants of cd T cell receptors.
Science 308, 252–255.
[19] Koch, M. et al. (2007) Structures of an MHC class I molecule from B21 chickens
illustrate promiscuous peptide binding. Immunity 27, 885–899.
[20] Hee, C.S., Gao, S., Loll, B., Miller, M.M., Uchanska-Ziegler, B., Daumke, O. and
Ziegler, A. (2010) Structure of a classical MHC class I molecule that binds
‘‘non-classical’’ ligands. PLoS Biol. 8, e1000557.
[21] Loconto, J. et al. (2003) Functional expression of murine V2R pheromone
receptors involves selective association with the M10 and M1 families of MHC
class Ib molecules. Cell 112, 607–618.
[22] Olson, R., Huey-Tubman, K.E., Dulac, C. and Bjorkman, P.J. (2005) Structure of a
pheromone receptor-associated MHC molecule with an open and empty
groove. PLoS Biol. 3, e257.
[23] Treiner, E. et al. (2003) Selection of evolutionarily conserved mucosal-
associated invariant T cells by MR1. Nature 422, 164–169.
[24] Huang, S., Gilﬁllan, S., Cella, M., Miley, M.J., Lantz, O., Lybarger, L., Fremont,
D.H. and Hansen, T.H. (2005) Evidence for MR1 antigen presentation to
mucosal-associated invariant T cells. J. Biol. Chem. 280, 21183–21193.
[25] Le Bourhis, L. et al. (2010) Antimicrobial activity of mucosal-associated
invariant T cells. Nat. Immunol. 11, 701–708.
[26] Abos, B., Gomez Del Moral, M., Gozalbo-Lopez, B., Lopez-Relano, J., Viana, V.
and Martinez-Naves, E. (2011) Human MR1 expression on the cell surface is
acid sensitive, proteasome independent and increases after culturing at 26
degrees C. Biochem. Biophys. Res. Commun. 411, 632–636.
[27] Shimamura, M. et al. (2007) Modulation of Va19 NKT cell immune responses
by a-mannosyl ceramide derivatives consisting of a series of modiﬁed
sphingosines. Eur J Immunol. 37, 1836–1844.
[28] Huang, S. et al. (2008) MR1 uses an endocytic pathway to activate mucosal-
associated invariant T cells. J. Exp. Med. 205, 1201–1211.
[29] Lafuente, E.M. and Reche, P.A. (2009) Prediction of MHC-peptide binding: a
systematic and comprehensive overview. Curr. Pharm. Des. 15, 3209–3220.
